Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space

#COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a

Detalles Bibliográficos
Autores principales: Orfanos, Sarah, El Husseini, Ibrahim, Nahass, Thomas, Radbel, Jared, Hussain, Sabiha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533378/
https://www.ncbi.nlm.nih.gov/pubmed/33043052
http://dx.doi.org/10.1183/23120541.00455-2020
_version_ 1783590119733723136
author Orfanos, Sarah
El Husseini, Ibrahim
Nahass, Thomas
Radbel, Jared
Hussain, Sabiha
author_facet Orfanos, Sarah
El Husseini, Ibrahim
Nahass, Thomas
Radbel, Jared
Hussain, Sabiha
author_sort Orfanos, Sarah
collection PubMed
description #COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a
format Online
Article
Text
id pubmed-7533378
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-75333782020-10-09 Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space Orfanos, Sarah El Husseini, Ibrahim Nahass, Thomas Radbel, Jared Hussain, Sabiha ERJ Open Res Original Research Letters #COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a European Respiratory Society 2020-10-05 /pmc/articles/PMC7533378/ /pubmed/33043052 http://dx.doi.org/10.1183/23120541.00455-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Research Letters
Orfanos, Sarah
El Husseini, Ibrahim
Nahass, Thomas
Radbel, Jared
Hussain, Sabiha
Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_full Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_fullStr Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_full_unstemmed Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_short Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_sort observational study of the use of recombinant tissue-type plasminogen activator in covid-19 shows a decrease in physiological dead space
topic Original Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533378/
https://www.ncbi.nlm.nih.gov/pubmed/33043052
http://dx.doi.org/10.1183/23120541.00455-2020
work_keys_str_mv AT orfanossarah observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace
AT elhusseiniibrahim observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace
AT nahassthomas observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace
AT radbeljared observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace
AT hussainsabiha observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace

Ejemplares similares